GRAL Reports $40.8M Revenue, $93.2M Net Loss, 28% YoY Growth, 50% Test Volume Rise, Epic Integration Planned, $823.1M Cash Position
GRAIL, Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $64.40
+15% in 1d after detection
Post-detection moves
1h
—
1d
+15%
3d
+13%
7d
+14%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS